Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chiya Leibovitch"'
Autor:
Ronit Gurion, Uri Rozovski, Gilad Itchaki, Anat Gafter-Gvili, Chiya Leibovitch, Pia Raanani, Haim Ben-Zvi, Moran Szwarcwort, Mor Taylor-Abigadol, Eldad J. Dann, Nurit Horesh, Tsofia Inbar, Inna Tzoran, Noa Lavi, Riva Fineman, Shimrit Ringelstein-Harlev, Netanel A. Horowitz
Publikováno v:
Haematologica, Vol 107, Iss 3 (2021)
Patients with lymphoma, especially those treated with anti-CD20 monoclonal antibodies, suffer high COVID-19-associated morbidity and mortality. The goal of this study was to assess the ability of lymphoma patients to generate a sufficient humoral res
Externí odkaz:
https://doaj.org/article/c1dde55d416f4a95b6372ab8f7d798dd
Autor:
Alona Telerman, Galit Granot, Chiya Leibovitch, Osnat Yarchovsky-Dolberg, Adi Shacham-Abulafia, Shirly Partouche, Moshe Yeshurun, Martin H. Ellis, Pia Raanani, Ofir Wolach
Publikováno v:
Cancers, Vol 14, Iss 1, p 119 (2021)
Cardiovascular complications are increasingly reported with the use of certain tyrosine kinase inhibitors (TKIs) to treat chronic myeloid leukemia (CML). We studied neutrophil extracellular trap (NET) formation in CML and evaluated the effect of TKIs
Externí odkaz:
https://doaj.org/article/be7021ddfe4c435b8a320bfa7005a8d1
Autor:
Alon Rozental, Erez Halperin, Chiya Leibovitch, Merav Barzilai, Uri Rozovski, Pia Raanani, Adi Shacham Abulafia
Publikováno v:
Blood. 140:9629-9630
Autor:
Gilad Itchaki, Inna Tzoran, Tsofia Inbar, Netanel A. Horowitz, Nurit Horesh, Eldad J. Dann, Moran Szwarcwort, Noa Lavi, Ronit Gurion, Mor Taylor-Abigadol, Chiya Leibovitch, Uri Rozovski, Anat Gafter-Gvili, Pia Raanani, Haim Ben-Zvi, Shimrit Ringelstein-Harlev, Riva Fineman
Publikováno v:
Haematologica. 107(3)
Patients with lymphoma, especially those treated with anti-CD20 monoclonal antibodies, suffer high COVID-19-associated morbidity and mortality. The goal of this study was to assess the ability of lymphoma patients to generate a sufficient humoral res
Publikováno v:
OBM Hepatology and Gastroenterology. 4
The current study aimed to investigate the effect of a multi-species probiotic (MSP) on cytokine production by human peripheral blood mononuclear cells (PBMCs) and their immune dialogue with HT-29 colon cancer cells. PBMCs were incubated with MSP and
Autor:
Ofir Wolach, Alona Telerman, Chiya Leibovitch, Osnat Yarchovsky-Dolberg, Adi Shacham-Abulafia, Shirly Partouche, Moshe Yeshurun, Martin Ellis, Pia Raanani, Galit Granot
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S225
Autor:
Osnat Yarchovsky-Dolberg, Alona Telerman, Adi Shacham-Abulafia, Pia Raanani, Chiya Leibovitch, Ofir Wolach, Shirly Partouche, Martin Ellis, Moshe Yeshurun, Galit Granot
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S332
Context: Cardiovascular (CVS) complications are increasingly reported with the use of certain tyrosine kinase inhibitors (TKIs) to treat chronic myeloid leukemia (CML). Neutrophil extracellular traps (NETs) have previously been implicated in the path
Autor:
Hefziba Green, Meir Lahav, Daniel Shepshelovich, Benaya Rozen-Zvi, Shirit Zoldan, Tzippy Shochat, Chiya Leibovitch, Alina Klein, Anat Gafter-Gvili
Publikováno v:
European Journal of Internal Medicine. 32:60-64
Purpose To determine the proportion of patients for whom the syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the presenting symptom of an underlying disorder, to describe the yield of different diagnostic modalities for patients w
Autor:
Benaya Rozen-Zvi, Gai Milo, Meir Lahav, Chiya Leibovitch, Shirit Zoldan, Tzippy Shochat, Daniel Shepshelovich, Anat Gafter-Gvili, Alina Klein
Publikováno v:
European Journal of Internal Medicine. 26:819-824
To determine the distribution of etiologies for the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in hospitalized patients and to characterize patients according to the different etiologies.A single-center retrospective study inclu
Autor:
Yakir Moshe, Ofir Wolach, Arie Apel, Avraham Frisch, Natalia Kreiniz, Chiya Leibovitch, Yishay Ofran, Maya Koren-Michowitz
Publikováno v:
Blood. 134:3902-3902
Background Newly diagnosed AML patients who cannot tolerate intensive chemotherapy have limited treatment options and poor long-term outcomes. Recently, the U.S FDA approved combination of venetoclax, an anti BCL-2 oral agent with hypomethylating age